Yiwen Zhang

Yiwen Zhang

Auto-generated profile, based on publicly available information

Yiwen Zhang

Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2025 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
LZLonggang Zhao
Longgang Zhao
YZYiwen Zhang
Yiwen Zhang
Jihong LiuJihong Liu
Jihong Liu
JHJames Hebert
James Hebert
EGEdward Giovannucci
Edward Giovannucci
SSSusan E. Steck
Susan E. Steck

14 September 2022 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
APAnna Plym
Anna Plym
YZYiwen Zhang
Yiwen Zhang
KSKonrad H. Stopsack
Konrad H. Stopsack
YJYon Ho Jee
Yon Ho Jee
FWFredrik Wiklund
Fredrik Wiklund
LMLorelei A. Mucci
Lorelei A. Mucci
Purpose: Family history of prostate cancer is one of the few universally accepted risk factors for prostate cancer. How much an assessment of inherited polygenic risk for prostate cancer adds to lifetime risk stratification beyond family history is unknown. Experimental Design: We followed 10,120 men in the Health Professionals Follow-up Study with existing genotype data for risk of prostate cancer and prostate cancer–specific death. We assessed to what extent family history of prostate or breast cancer, combined with a validated polygenic risk score (PRS) including 269 prostate cancer risk variants, identifies men at risk of prostate cancer and prostate cancer death across the age span. Results: During 20 years of follow-up, 1,915 prostate cancer and 166 fatal prostate cancer events were observed. Men in the top PRS quartile with a family history of prostate or breast cancer had the highest rate of both prostate cancer and prostate cancer–specific death. Compared with men at lowest genetic risk (bottom PRS quartile and no family history), the HR was 6.95 [95% confidence interval (CI), 5.57–8.66] for prostate cancer and 4.84 (95% CI, 2.59–9.03) for prostate cancer death. Men in the two upper PRS quartiles (50%–100%) or with a family history of prostate or breast cancer (61.8% of the population) accounted for 97.5% of prostate cancer deaths by age 75 years. Conclusions: Our study shows that prostate cancer risk stratification on the basis of family history and inherited polygenic risk can identify men at highest risk of dying from prostate cancer before age 75 years.

1 January 2024 in Hypertension
Verified
Journal Article
Closed access
YMYuan Ma
Yuan Ma
YZYiwen Zhang
Yiwen Zhang
JCJosef Coresh
Josef Coresh
AVAnand Viswanathan
Anand Viswanathan
KSKevin J. Sullivan
Kevin J. Sullivan
SJStephen P. Juraschek
Stephen P. Juraschek
BACKGROUND: Abnormal orthostatic blood pressure (BP) regulation may result in cerebral hypoperfusion and brain ischemia and contribute to dementia. It may also manifest as early symptoms of the neurodegenerative process associated with dementia. The relationship between the magnitude and timing of orthostatic BP responses and dementia risk is not fully understood. METHODS: We conducted a prospective cohort analysis of the associations of orthostatic BP changes and self-reported orthostatic dizziness with the risk of dementia in the Atherosclerosis Risk in Communities study (ARIC). We calculated changes in BP from the supine to the standing position at 5 measurements taken within 2 minutes after standing during the baseline visit (1987–1989). The primary outcome was adjudicated dementia ascertained through 2019. RESULTS: Among 11 644 participants (mean [SD] age, 54.5 [5.7] years; 54.1% women; 25.9% Black), 2303 dementia cases were identified during a median follow-up of 25.9 years. Large decreases in systolic BP from the supine to standing position measured at the first 2 measurements ≈30 and 50 seconds after standing, but not afterward, were associated with orthostatic dizziness and a higher risk of dementia. Comparing a decrease in systolic BP of ≤−20 or >−20 to −10 mm Hg to stable systolic BP (>−10 to 10 mm Hg) at the first measurement, the adjusted hazard ratios were 1.22 (95% CI, 1.01–1.47) and 1.10 (95% CI, 0.97–1.25), respectively. CONCLUSIONS: Abnormal orthostatic BP regulation, especially abrupt drops in BP within the first minute, might be early risk markers for the development of dementia. Transient early orthostatic hypotension warrants more attention in clinical settings.

1 December 2019 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
YZYiwen Zhang
Yiwen Zhang
CZCindy Ke Zhou
Cindy Ke Zhou
EREmily M. Rencsok
Emily M. Rencsok
KFKatja Fall
Katja Fall
TLTamara L. Lotan
Tamara L. Lotan
EEEricka M. Ebot
Ericka M. Ebot
Background: Inflammation and focal atrophy are common features adjacent to prostate tumors. Limited evidence exists on whether these features have prognostic significance. Methods: In the Health Professionals Follow-Up Study and Physicians' Health Study, we studied 1,035 men diagnosed with prostate cancer. A genitourinary pathologist centrally reviewed tumor and normal areas of hematoxylin and eosin slides from prostate cancer specimens for the presence of acute and chronic inflammation, and four subtypes of focal atrophy. Cox proportional hazards models adjusted for potential confounders were used to estimate HRs and 95% confidence intervals (CI) for the association of these features with lethal prostate cancer, defined as development of metastatic disease or death during follow-up. Results: During a median of 12 years of follow-up, 153 men developed lethal prostate cancer. A total of 84% of men had histologic evidence of chronic inflammation and 30% had acute inflammation. Both chronic and acute inflammation were inversely associated with lethal prostate cancer in age- and lifestyle-adjusted models. Chronic inflammation remained inversely associated with lethal prostate cancer after additionally adjusting for prognostic clinical features (HR = 0.45; 95% CI, 0.30–0.69 for mild and HR = 0.51; 95% CI, 0.33–0.80 for moderate to severe). None of the atrophic lesions were associated with lethal prostate cancer. Conclusions: Our data suggest that the presence of inflammation, particularly chronic inflammation, in prostate cancer tissue is associated with better prognosis among patients with prostate cancer. Impact: This is the largest prospective cohort study to examine the association between inflammation, focal atrophy, and lethal prostate cancer.

22 December 2023 in Urban Forestry & Urban Greening
Verified
Journal Article
Closed access
YWYutong Wang
Yutong Wang
Shan LuShan Lu
Shan Lu
MXMeijing Xu
Meijing Xu
YZYiwen Zhang
Yiwen Zhang
FXFeng Xu
Feng Xu

1 February 2025 in Hypertension
Verified
Journal Article
Closed access
YMYuan Ma
Yuan Ma
YZYiwen Zhang
Yiwen Zhang
RHRikuta Hamaya
Rikuta Hamaya
BWBerend E. Westerhof
Berend E. Westerhof
HSHossam A. Shaltout
Hossam A. Shaltout
MIM. Arfan Ikram
M. Arfan Ikram
BACKGROUND: Increased blood pressure (BP) variability is linked to dementia risk, but the relationship between baroreflex sensitivity (BRS), a fundamental mechanism for maintaining stable BP, and dementia risk is undetermined. METHODS: We tested the hypothesis that impaired BRS is associated with increased dementia risk in 1819 older adults (63% women; age, 71.0±6.3 years) from the community-based Rotterdam Study. Cardiac BRS was determined from a 5-minute beat-to-beat BP recording at supine rest between 1997 and 1999. Cardiac BRS measures the correlation between changes in consecutive beat-to-beat systolic BP and subsequent responses in heartbeat intervals, with a higher value indicating better BRS. The primary outcome was incident dementia ascertained from baseline through January 1, 2020; the secondary outcome was all-cause mortality. RESULTS: During a median follow-up of 14.8 years, 421 participants developed dementia. The association of cardiac BRS with dementia risk differed by antihypertensive medication use ( P interaction =0.03) and was only observed in participants not taking antihypertensives. Specifically, in those not taking antihypertensive medication, reduced BRS was associated with a higher risk of dementia (adjusted hazard ratio comparing bottom versus top quintiles, 1.60 [95% CI, 1.07–2.40]; P trend =0.02). Reduced BRS was also associated with an increased risk of death (corresponding hazard ratio, 1.76 [95% CI, 1.32–2.35]). The association remained after adjusting for average BP and BP variability. CONCLUSIONS: Impaired BRS partly explains hypertension-related brain damage and excessive dementia risk beyond conventional BP measures, making it a potential novel biomarker for the early detection and prevention of dementia.